New York, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Computer Aided Detection (CAD) Industry" - https://www.reportlinker.com/p05817909/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year
Global Computer Aided Detection (CAD) Market to Reach $1.5 Billion by 2027
Amid the COVID-19 crisis, the global market for Computer Aided Detection (CAD) estimated at US$783.2 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027. Mammography, one of the segments analyzed in the report, is projected to record a 10.3% CAGR and reach US$550.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the MRI segment is readjusted to a revised 9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $213.4 Million, While China is Forecast to Grow at 12.9% CAGR
The Computer Aided Detection (CAD) market in the U.S. is estimated at US$213.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$309.9 Million by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.
Ultrasound Imaging Segment to Record 7.2% CAGR
In the global Ultrasound Imaging segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$82.5 Million in the year 2020 will reach a projected size of US$129.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$209.1 Million by the year 2027, while Latin America will expand at a 8.6% CAGR through the analysis period.
Select Competitors (Total 103 Featured) -
Agfa-Gevaert NV
FUJIFILM Holdings Corporation
GE Healthcare
Hitachi Ltd.
Hologic, Inc.
iCAD, Inc.
Invivo Corporation
Koninklijke Philips NV
McKesson Corporation
Merge Healthcare, Inc.
Siemens Healthineers
Read the full report: https://www.reportlinker.com/p05817909/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Computer Aided Detection (CAD) - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 3: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for
Cardiovascular & Neurological Indications by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 5: World Historic Review for Cardiovascular &
Neurological Indications by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Cardiovascular &
Neurological Indications by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Mammography by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Mammography by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Mammography by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for MRI
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for MRI by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for MRI by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Ultrasound Imaging by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Ultrasound Imaging by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Ultrasound Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Tomosynthesis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Tomosynthesis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for Tomosynthesis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for CT
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for CT by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for CT by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2012, 2021 & 2027
Table 22: World Recent Past, Current & Future Analysis for
Other Imaging Modalities by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Other Imaging Modalities by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Other Imaging
Modalities by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 25: World Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Computer Aided Detection
(CAD) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Computer Aided
Detection (CAD) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2021 & 2027
Table 28: World Computer Aided Detection (CAD) Market Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2022
(E)
Table 29: USA Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 30: USA Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 31: USA 15-Year Perspective for Computer Aided Detection
(CAD) by Application - Percentage Breakdown of Value Sales for
Oncology and Cardiovascular & Neurological Indications for the
Years 2012, 2021 & 2027
Table 32: USA Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 33: USA Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 34: USA 15-Year Perspective for Computer Aided Detection
(CAD) by Imaging Modality - Percentage Breakdown of Value Sales
for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities for the Years 2012, 2021 & 2027
CANADA
Table 35: Canada Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 36: Canada Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 37: Canada 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 38: Canada Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 39: Canada Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 40: Canada 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
JAPAN
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 41: Japan Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 42: Japan Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 43: Japan 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 44: Japan Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 45: Japan Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 46: Japan 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
CHINA
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2022 (E)
Table 47: China Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 48: China Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 49: China 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 50: China Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 51: China Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 52: China 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
EUROPE
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 53: Europe Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 54: Europe Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 55: Europe 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 56: Europe Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 57: Europe Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 58: Europe 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
Table 59: Europe Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 60: Europe Historic Review for Computer Aided Detection
(CAD) by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 61: Europe 15-Year Perspective for Computer Aided
Detection (CAD) by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2021 & 2027
FRANCE
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2022 (E)
Table 62: France Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 63: France Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 64: France 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 65: France Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 66: France Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 67: France 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
GERMANY
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 68: Germany Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 69: Germany Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 70: Germany 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 71: Germany Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 72: Germany Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 73: Germany 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
ITALY
Table 74: Italy Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 75: Italy Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 76: Italy 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 77: Italy Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 78: Italy Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 79: Italy 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
UNITED KINGDOM
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for
2022 (E)
Table 80: UK Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 81: UK Historic Review for Computer Aided Detection (CAD)
by Application - Oncology and Cardiovascular & Neurological
Indications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 82: UK 15-Year Perspective for Computer Aided Detection
(CAD) by Application - Percentage Breakdown of Value Sales for
Oncology and Cardiovascular & Neurological Indications for the
Years 2012, 2021 & 2027
Table 83: UK Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 84: UK Historic Review for Computer Aided Detection (CAD)
by Imaging Modality - Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 85: UK 15-Year Perspective for Computer Aided Detection
(CAD) by Imaging Modality - Percentage Breakdown of Value Sales
for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities for the Years 2012, 2021 & 2027
SPAIN
Table 86: Spain Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 87: Spain Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 88: Spain 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 89: Spain Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 90: Spain Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 91: Spain 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
RUSSIA
Table 92: Russia Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 93: Russia Historic Review for Computer Aided Detection
(CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 94: Russia 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 95: Russia Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 96: Russia Historic Review for Computer Aided Detection
(CAD) by Imaging Modality - Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 97: Russia 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
REST OF EUROPE
Table 98: Rest of Europe Recent Past, Current & Future Analysis
for Computer Aided Detection (CAD) by Application - Oncology
and Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 99: Rest of Europe Historic Review for Computer Aided
Detection (CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 100: Rest of Europe 15-Year Perspective for Computer
Aided Detection (CAD) by Application - Percentage Breakdown of
Value Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 101: Rest of Europe Recent Past, Current & Future
Analysis for Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 102: Rest of Europe Historic Review for Computer Aided
Detection (CAD) by Imaging Modality - Mammography, MRI,
Ultrasound Imaging, Tomosynthesis, CT and Other Imaging
Modalities Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 103: Rest of Europe 15-Year Perspective for Computer
Aided Detection (CAD) by Imaging Modality - Percentage
Breakdown of Value Sales for Mammography, MRI, Ultrasound
Imaging, Tomosynthesis, CT and Other Imaging Modalities for the
Years 2012, 2021 & 2027
ASIA-PACIFIC
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 104: Asia-Pacific Recent Past, Current & Future Analysis
for Computer Aided Detection (CAD) by Application - Oncology
and Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 105: Asia-Pacific Historic Review for Computer Aided
Detection (CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 106: Asia-Pacific 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 107: Asia-Pacific Recent Past, Current & Future Analysis
for Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Other Imaging Modalities - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 108: Asia-Pacific Historic Review for Computer Aided
Detection (CAD) by Imaging Modality - Mammography, MRI,
Ultrasound Imaging, Tomosynthesis, CT and Other Imaging
Modalities Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 109: Asia-Pacific 15-Year Perspective for Computer Aided
Detection (CAD) by Imaging Modality - Percentage Breakdown of
Value Sales for Mammography, MRI, Ultrasound Imaging,
Tomosynthesis, CT and Other Imaging Modalities for the Years
2012, 2021 & 2027
Table 110: Asia-Pacific Recent Past, Current & Future Analysis
for Computer Aided Detection (CAD) by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2020 through 2027 and % CAGR
Table 111: Asia-Pacific Historic Review for Computer Aided
Detection (CAD) by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 112: Asia-Pacific 15-Year Perspective for Computer Aided
Detection (CAD) by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027
AUSTRALIA
Computer Aided Detection (CAD) Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Australia for 2022 (E)
Table 113: Australia Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Application - Oncology and
Cardiovascular & Neurological Indications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 114: Australia Historic Review for Computer Aided
Detection (CAD) by Application - Oncology and Cardiovascular &
Neurological Indications Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 115: Australia 15-Year Perspective for Computer Aided
Detection (CAD) by Application - Percentage Breakdown of Value
Sales for Oncology and Cardiovascular & Neurological
Indications for the Years 2012, 2021 & 2027
Table 116: Australia Recent Past, Current & Future Analysis for
Computer Aided Detection (CAD) by Imaging Modality -
Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05817909/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
